Clinical Trial Update: Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting a double-blind comparison of C213 to placebo for acute treatment of cluster headaches across Phase 2 and Phase 3, with completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cluster Headache

Drugs mentioned

• C213

Snippet

Sponsor: Zosano Pharma Corporation | Conditions: Cluster Headache | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-05-02